REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 191 filers reported holding REVANCE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Campbell & CO Investment Adviser LLC | 100,907 | $1,157,403 | 0.14% |
| Hunting Hill Global Capital, LLC | 26,900 | $308,543 | 0.10% |
| HARBOR CAPITAL ADVISORS, INC. | 40,999 | $470,259 | 0.10% |
| Centiva Capital, LP | 314,661 | $3,609,162 | 0.08% |
| Legato Capital Management LLC | 38,749 | $444,451 | 0.06% |
| Summit X, LLC | 17,645 | $202,468 | 0.06% |
| FOX RUN MANAGEMENT, L.L.C. | 18,360 | $210,589 | 0.06% |
| Caption Management, LLC | 308,300 | $3,536,201 | 0.05% |
| Point72 Asset Management, L.P. | 1,363,168 | $15,635,537 | 0.05% |
| Virtu Financial LLC | 36,377 | $417 | 0.04% |
| XTX Topco Ltd | 19,908 | $228,345 | 0.04% |
| Inspire Investing, LLC | 26,592 | $305,010 | 0.04% |
| BAMCO INC /NY/ | 1,020,234 | $11,702,084 | 0.03% |
| MOORE CAPITAL MANAGEMENT, LP | 160,000 | $1,835,200 | 0.03% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 544,447 | $6,244,807 | 0.03% |
| NJ State Employees Deferred Compensation Plan | 17,900 | $205,313 | 0.03% |
| Capital World Investors | 11,960,820 | $137,190,605 | 0.03% |
| UBS OCONNOR LLC | 88,800 | $1,018,536 | 0.03% |
| Centiva Capital, LP | 100,100 | $1,148,147 | 0.02% |
| CENTAURUS FINANCIAL, INC. | 24,527 | $281 | 0.02% |
External links
This page lists REVANCE THERAPEUTICS INC's shareholders in Q3 2023. To view REVANCE THERAPEUTICS INC's shareholder history, click here.